别名:COP; COP1; PSEUDO-ICE应用:WB,IHC
反应种属:Human
规格:50μl/100μl
Description |
---|
Caspase inhibitor. Acts as a regulator of procaspase-1/CASP1 activation implicated in the regulation of the proteolytic maturation of pro-interleukin-1 beta (IL1B) and its release during inflammation. Inhibits the release of IL1B in response to LPS in monocytes. Also induces NF-kappa-B activation during the pro-inflammatory cytokine response. Also able to inhibit CASP1-mediated neuronal cell death, TNF-alpha, hypoxia-, UV-, and staurosporine-mediated cell death but not ER stress-mediated cell death. Acts by preventing activation of caspases CASP1 and CASP4, possibly by preventing the interaction between CASP1 and RIPK2. |
Specification | |
---|---|
Aliases | COP; COP1; PSEUDO-ICE |
Swissprot | Q5EG05 |
WB Predicted band size | 23 kDa |
Host/Isotype | Rabbit IgG |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | Synthetic peptide of human CARD16 |
Formulation | pH7.4 PBS, 0.05% NaN3, 40% Glycerol |
Application | |
---|---|
WB | 1/500-1/2000 |
IHC | 1/40-1/200 |
ELISA | 1/5000-1/10000 |
Gel: 12%SDS-PAGE, Lysate: 40 μg, Lane: Human placenta tissue lysate, Primary antibody: P06219(CARD16 Antibody) at dilution 1/800, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 60 seconds | |
The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P06219(CARD16 Antibody) at dilution 1/55. (Original magnification: ×200) |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
发表回复